Chelonia Collaborations bring together groups of outstanding scientists to address topics of fundamental scientific importance in which a significant new development has created a novel area for exploration in an established field and possibly new applications into real-life.
Chelonia Collaboration on Drug Discovery and AI
Chelonia leads the business development and communication of Exscalate drug discovery platform developed by its partner Dompé farmaceutici SpA . Using HPC and AI, Exscalate is the most advanced computational platform to accelerate lead discovery and lead optimization.
Chelonia Collaboration on vector-borne diseases
Climate change is already affecting vector-borne disease transmission and spread, and its impacts are likely to worsen. In the face of ongoing climate change, Chelonia wants to intensify efforts to prevent and control vector-borne diseases.
Chelonia Collaboration with Istituto Mario Negri
Chelonia and Istituto Mario Negri collaborates in R&D projects aiming to discover new biomarkers in oncology or new pharmacological compounds using AI and ML.